Hematologic Cancer
Oncology·MeSH: Hematologic Neoplasms
3 drugs in development·3 companies·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| CX-2029 | CytomX Therapeutics, Inc. (CTMX) |
Phase 1(1)
| Drug | Company |
|---|---|
| abbv-101 | AbbVie Inc. (ABBV) |
Preclinical(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Hematologic Cancer?
BioSniper tracks 3 drugs in development for Hematologic Cancer across 3 companies.
How many clinical trials target Hematologic Cancer?
There are 1 clinical trial targeting Hematologic Cancer tracked by BioSniper.
Deep-dive into Hematologic Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis